Intarcia Therapeutics

Discussion in 'Intarcia Therapeutics' started by anonymous, Mar 31, 2017 at 10:22 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    so when Bayer had the pump it was an apple, then you have it and you call it an orange ?

    that just doest make sense
     

  2. anonymous

    anonymous Guest

    Thanks but pray for your company. And Please don't lie to sales reps; we have heard enough management " change healthcare" silliness
     
  3. anonymous

    anonymous Guest

    It's simple math Intarcia marketing troll chump.

    So which payer is going to fork out 4X more for your bout to patent expire pump vs. slew of PROVEN weekly GLP-1 drugs? OK maybe for those few % with history of emergency room visits provided the patients don't mind that foreign POS in their tummy and multiple surgeries which itself begs the question of is that part of the pump cost or extra? Anyone who has been to urgent care for few stitches know how expensive these minor surgeries get.

    Comparing twice daily Byetta, well known shitty formula that AstraZeneca gave away to Teva for pittance, to your implant is comparing real apple to apple to ya? As for made up Ph II data about 2% nausea rate - hell that's way below all other marketed GLP-1s when your pump has very concentrated dose?

    But that is if you chumps can hide the weenie from FDA on KNOWN impurities issue, huh?
     
  4. anonymous

    anonymous Guest


    As I said before. Go back to big pharma and the bottle. You are not cut for a start-up that is about to change the world. You don't understand managed care at all and you obviously don't understand why patent life doesn't matter. Go away. Stay in big pharma and die a slow death.
     
  5. anonymous

    anonymous Guest


    You obviously don't understand pharmacoeconomics. Just 1 hospital visit costs tens of thousands of dollars. If Intarcia can have 100% compliance, which it can with the implant, then it can reduce hospital admissions. 1 Hospital admission saved will treat hundreds of patients. Since you don't know who will be compliant on GLP-1 drugs and who will not it makes sense to get people off the unknown therapy and onto the known 100% compliance product. Statistics matter and if Intarcia can get even a 1% reduction in hospital admissions it will save managed care companies millions. This is simple math and MCO's get it. It appears you don't understand this and you are a low information pharma person. Stay in big pharma and go make calls and drop samples.
     
  6. anonymous

    anonymous Guest

    More BS gobbledygook from minds of marketing bozos holed up too long in the office. Been out in the field much?

    It's all about cost! You think the payers really gives shit about patients? It's all $$$s chump.

    Now why won't you respond about prohibitive costs on 1st year (vs. $5k for weekly GLP-1):

    1. 3-month starter implant plus implantation surgery
    2. 6-month implant plus explantatiion and implantation surgeries
    3. 9-month implant plus explantatiion and implantation surgeries

    And if patents demand that implant be removed due to nasty side effects - who will pay? It's not like stop taking pills or injection.

    How many physicians used to writing prescriptions will embrace performing surgeries in their office (not to mention follow-ups and other complications, malpractice, etc)?

    Just hope for fraction of a percent at best and yeah big pharmas will crush Intarcia to smithereens.
     
  7. anonymous

    anonymous Guest


    Like I said before cost savings to mco is reason they will cover but your too uneducated to understand. Doctors will do procedure because its a revenue stream. GPs will like the?added revenue. Why give money to just pharma company with an rx when you the doctor can also make money? Too bad u didnt make the cut to work at Intarcia
     
  8. anonymous

    anonymous Guest

    Thanks - sounds good. How much will gp make per insertion ? How would you model revenue stream for a GP who has 25 pts on bayetta/bydureon and switches them to INTC implant ? Is it the first year revenue that is the most attractive (3 insertions/2 withdrawls) ? I know my docs would go for this once they know how much they can make.
     
  9. anonymous

    anonymous Guest

    Now you understand - sell the spread - docs love to make money and this is the way to get use
     
  10. anonymous

    anonymous Guest

    Is it really all about Hayweird ? Boston seems like the Castro
     
  11. anonymous

    anonymous Guest

    Is this open ? Can you advise on bonus salary car and launch date. Serious replies only. Thanks
     
  12. anonymous

    anonymous Guest

    Rep positions should be posted soon. Salaries should be commensurate with med device reps and should be high bonus potential. car allowance. Launch probably first quarter 2018. Most likely contingency offers to reps once the product is approved. All guesses though.
     
  13. anonymous

    anonymous Guest

    Right genius - alas if the managed care payers will the pick up the Intracia's and docs fat profit margins...

    What is the target cost to the payer for the 1st year with the juicy doc spreads, again?
     
  14. anonymous

    anonymous Guest

    Congratulations and good luck. Maybe for your sake they'll overcome age discrimination in a decade or two.
     
  15. anonymous

    anonymous Guest


    So you think you got passed up because of your age? Really? Explain what background you had and then why you thought age was the motivating factor?
     
  16. anonymous

    anonymous Guest

    Who showed off the lifestyle?
     
  17. anonymous

    anonymous Guest

    So who are the "real men" in charge in Boston and Hayweird? Guess picking up and hiring gay men for manly love is the modus operandi at the company's critical juncture? Bunch of sickos...

    No thanks as the obligatory visit to the local bathhouses part of final interviews?
     
  18. anonymous

    anonymous Guest


    Still wondering who this so called "leader" was that showed off his lover? Please expand original poster...
     
  19. anonymous

    anonymous Guest

    Take your best candidate and multiply their experience and awards by 3.
     
  20. anonymous

    anonymous Guest

    whoa slow down nelly

    If you are too talented then you might compete for daddy's attention

    There can only be one best boy